Mike Hennessy
Articles
When You Hear Hoof Beats, Think Zebras
March 23, 2016
Article
Diagnosing and treating a patient with a less common cancer can be challenging for practitioners, yet with greater awareness and better diagnostics more of these rare cancers are likely to show up in the clinic.
Improving Quality of Life Throughout the Care Continuum
February 23, 2016
Article
The FDA has been very busy lately granting approvals for a host of new anticancer agents, drug combinations, and indications.
Celebrating a Season of Hope and Progress
December 01, 2015
Article
What a year it has been for FDA approvals in oncology! With the holidays upon us, there is much to be thankful for in the world of cancer research, where advances in understanding tumor biomarkers have ushered in a host of new personalized therapies for many patients.
Caring for the Whole Patient-for Nurses, It Comes Naturally
October 25, 2015
Article
More and more Americans are embracing complementary medicine to help manage their illnesses alongside conventional therapies, and in oncology, nurses know well how important these interventions can be to improving patient and survivor quality of life.
Keeping Watch: Monitoring Survivors for Late Treatment Effects
September 16, 2015
Article
We continue to marvel at the tremendous strides made in cancer care, a record of progress that means millions of people are now surviving cancer, and many for a very long time.
Bringing You the Latest Updates From the Year's Largest Oncology Conference
August 25, 2015
Article
When some 30,000 oncology practitioners, researchers, and patient advocates gather each year for the annual meeting of the American Society of Clinical Oncology (ASCO), we've come to count on some pretty important research updates emerging from that gathering. This year's meeting-ASCO's 51st-proved no exception.
Immunotherapy-Transforming Cancer Care, Offering Patients New Hope
June 18, 2015
Article
It's really no surprise that the buzz at the major oncology meetings these days centers on how immunotherapy is being deployed in the treatment of many hard-to-treat cancers-moving far beyond the melanoma setting where the approach has already proven so successful.